Moneycontrol PRO

Coronavirus lockdown | Lodha Developers sells 300 units across projects

The group’s UK business has generated new sales of about Rs 150 crore during the period, the company said

Real estate developer Lodha Developers has claimed to have sold about 300 units across multiple projects in Mumbai region since the start of the lockdown about five weeks ago, the company said in a statement.

The group’s UK business has generated new sales of about Rs 150 crore during the period, the company said.

On Akshay Tritiya held on April 26, the group sold 80 units across its residential portfolio with several buyers preferring ready-to-move inventories and projects with integrated living, the company said in a statement.

The company also saw interest across its diversified commercial portfolio, particularly with regard to enquiries for industrial and logistics space.

“We have been receiving constant enquiries for properties. The Covid-19 lockdown has made us all realize that owning a home for our families is very important. Lower interest rates on home loans are also helping. Ready to move-in homes and projects with integrated living are witnessing high interest,” said Prashant Bindal, chief sales officer, Lodha Developers, said.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Lodha group had made a foray into the London market in 2013 with the acquisition of the landmark MacDonald House at 1 Grosvenor Square in prime Central London for over Rs 3,100 crore.

Moneycontrol News
first published: Apr 27, 2020 06:55 pm
ISO 27001 - BSI Assurance Mark